Business
Remdesivir study by World Health Organisation casts doubt, disputed by Gilead Sciences Inc – 7NEWS.com.au
The antiviral medication was one of the drugs used to treat US President Donald Trump after his COVID-19 diagnosis.
Gilead Sciences Inc has questioned the findings of a World Health Organisation (WHO) study that concluded its COVID-19 drug remdesivir does not help patients who have been admitted to hospital.
The American company told Reuters the data appeared inconsistent, the findings were premature and that other studies had validated the drugs benefits.
In a blow to one of the few drugs being used to treat people with COVID-19, the WHO said on Thursday its Solidarity trial had concluded that remdesivir a…
-
Noosa News21 hours agoPill checking to resume in Queensland months after government axed funding
-
Noosa News19 hours agoQueensland girl Millie’s fight for life after magnets tore through her bowel
-
General23 hours agoOlivia Colman and Benedict Cumberbatch rise to the occasion for The Roses
-
Noosa News19 hours agoMother who faked daughter’s medical conditions, forged documents, granted immediate parole